» Articles » PMID: 15268730

Long-term Renal Allograft Survival: Have We Made Significant Progress or is It Time to Rethink Our Analytic and Therapeutic Strategies?

Overview
Journal Am J Transplant
Publisher Elsevier
Specialty General Surgery
Date 2004 Jul 23
PMID 15268730
Citations 156
Authors
Affiliations
Soon will be listed here.
Abstract

Impressive renal allograft survival improvement between 1988 and 1995 has been described using projections of half-lives based on limited actual follow up. We aimed, now with sufficient follow up available to calculate real half-lives. Real half-lives calculated from Kaplan-Meier curves for the overall population as well as subsets of repeat transplants and African Americans recipients were examined. Real half-lives were substantially shorter than projected half-lives. As a whole, half-lives have improved by about 2 years between 1988 and 1995 as compared to the earlier projected 6 years of improvement. The improvement seems to be driven primarily by the improvement in graft survival of re-transplants. First transplants showed a cumulative increase in graft survival of less than 6 months. Projected half-lives are a risky estimation of long-term survival especially when based on short actual follow up. First transplant survival has only marginally improved during the early years of post transplant follow up while no significant improvement in long-term survival could be detected between 1988 and 1995. Redirection of attention from early endpoints towards the process of long-term graft loss may be necessary to sustain early gains in the long term.

Citing Articles

Detection and classification of glomerular lesions in kidney graft biopsies using 2-stage deep learning approach.

Fogaing I, Abdo A, Ballis-Berthiot P, Adrian-Felix S, Olagne J, Merieux R Medicine (Baltimore). 2025; 104(7):e41560.

PMID: 39960931 PMC: 11835116. DOI: 10.1097/MD.0000000000041560.


Torque Teno Virus: A Promising Biomarker in Kidney Transplant Recipients.

Dal Lago S, Brani P, Ietto G, Dalla Gasperina D, Gianfagna F, Giaroni C Int J Mol Sci. 2024; 25(14).

PMID: 39062987 PMC: 11277443. DOI: 10.3390/ijms25147744.


Long-Term Graft and Patient Survival After Re-Transplantation.

Bielopolski D, Gravetz A, Agur T, Yemini R, Rozen Zvi B, Nesher E Ann Transplant. 2024; 29:e943903.

PMID: 38902916 PMC: 11299480. DOI: 10.12659/AOT.943903.


Transplant Nephrectomy: A Comparative Study of Timing and Techniques in a Single Institution.

Pession U, Lammers I, Hauser I, Schreckenbach T, Schnitzbauer A, Lang J Ann Transplant. 2024; 29:e942252.

PMID: 38711249 PMC: 11088283. DOI: 10.12659/AOT.942252.


Urine microbiome in individuals with an impaired immune system.

Elsayed N, Wolfe A, Burk R Front Cell Infect Microbiol. 2024; 13:1308665.

PMID: 38274734 PMC: 10808152. DOI: 10.3389/fcimb.2023.1308665.